Salmeterol Fluticasone Rotacap Franchise in Ahmedabad

Salmeterol 50mcg + Fluticasone 250mcg Rota Capsule Supplier in Mumbai

Asthma & COPD Capsule Distributor in Delhi

Respiratory Therapy Rotacap Manufacturer in Bangalore

Bronchodilator Anti-Inflammatory Rotacap Stockist in Hyderabad
Salmeterol Fluticasone Rotacap Exporter in Chandigarh

Home/Products /fluticasone-propionate-xinafoate-rota-cap

About the Product

Description


Salmeterol 50mcg + Fluticasone Propionate 250mcg rota capsule is a combination inhalation therapy used for the effective management of asthma and COPD, providing improved airflow and symptom control.

Salmeterol acts as a long-acting beta-2 adrenergic bronchodilator, relaxing airway smooth muscles, while Fluticasone Propionate provides potent corticosteroid anti-inflammatory action, reducing airway inflammation and hyperresponsiveness.

This rotacap is commonly prescribed for maintenance therapy in persistent asthma, chronic bronchitis, and COPD, helping prevent exacerbations, reduce wheezing, and improve overall pulmonary function.

With clinically proven dual-action efficacy, patient-friendly administration, and consistent symptom relief, this formulation strengthens a respiratory therapy portfolio and supports sustained therapeutic demand.

Flutialfa SF 250 Rota Capsule is indicated for the maintenance treatment of asthma and COPD. It helps in preventing bronchospasm, controlling inflammation, and improving lung function, as prescribed by a healthcare professional.

Common side effects may include throat irritation, hoarseness, cough, oral thrush, tremors, or mild palpitations. Rarely, systemic corticosteroid effects or cardiovascular effects may occur with prolonged use.

For inhalation use only. Use under strict medical supervision. Not intended for acute asthma attacks; a rescue inhaler should be used for sudden symptoms. Rinse mouth after each use to prevent oral infections.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Fluticasone Propionate + Xinafoate Rotacap in the PCD pharma franchise market?

This rotacap is used in respiratory conditions like asthma and COPD, helping reduce airway inflammation and improve breathing, making it a strong pulmonology and respiratory segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this rotacap in their product range?

Medical distributors and wholesalers can benefit from steady demand in pulmonology clinics, respiratory hospitals, and chronic asthma/COPD treatment prescriptions. It is commonly prescribed for long-term maintenance therapy in patients with airway obstruction and inflammation.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Fluticasone-based respiratory rotacaps with monopoly rights, quality respiratory manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this respiratory product?

Wholesalers and medical agencies benefit from consistent chronic prescription demand, pulmonology clinic usage, and long-term respiratory therapy cycles when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for this rotacap?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this respiratory formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.